LexDanaLexDanabeta
Inventor

Markus Metz

Inventor
Delta, CA

Overview

9→
Patents
2009–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 9 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
A61KPreparations for medical, dental or toiletry purposes19%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium15%
PatentTitleYear
11,008,316Glucosylceramide synthase inhibitors202110,166,239Tropomyosin-related kinase (Trk) inhibitors20199,611,265'Tropomyosin-related kinase (TRK) inhibitors'20179,174,986'Tropomyosin-related kinase (Trk) inhibitors'20159,067,914'Tropomyosin-related kinase (TRK) inhibitors'20157,790,747'Chemokine receptor binding compounds'20107,550,484'Chemokine receptor binding heterocyclic compounds with enhanced efficacy'20097,498,346'Chemokine receptor binding compounds'20097,491,735'Chemokine receptor binding compounds'2009

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2009–2021Patents assigned to GENZYME CORP (9)· patent assignee history
2009–2010Based in Delta, CA· patent location history
2015–2017Based in Brookline, MA, US· patent location history
2019–2021Based in Encinitas, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GENZYME CORP92009–2021
Locations
LocationPatentsSpan
Delta, CA42009–2010
Brookline, Massachusetts, US32015–2017
Encinitas, California, US22019–2021